This study offers new profound insights into the LN metastasis of breast cancer cells, investigate the remodeling process of the LN microenvironment, and elucidate the role of GLO1 as a promising biomarker and therapeutic target for improving the treatment outcomes of patients with breast cancer. This evidence concerns the gene GLO1 and breast cancer.